Star Source Multi Trade share news, announcements and annual reports
BSE: 506365Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹111.00.
30 Oct: open ₹110.00, high ₹110.00, low ₹110.00
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17 Cr4,271st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1
Star Source Multi Trade share news and announcements
472 announcements, routine notices left out, newest first. Page 2 of 10.
Aug 2025
5 Aug · Board meeting
Meeting on 12 Aug 2025: annual general meeting and quarterly results
Jul 2025
28 Jul · Board meeting
Meeting on 31 Jul 202524 Jul · Management
9 Jul · Management
8 Jul · Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Jun 2025
19 Jun · Updates on Open Offer
May 2025
29 May · Board meeting
28 May · Updates on Open Offer
27 May · Intimation With Respect To Opening Of New Corporate Office Of The Company
21 May · Updates on Open Offer
20 May · Updates on Open Offer
14 May · Board meeting
Meeting on 29 May 2025: audited results13 May · Letter of Offer
2 May · Board meeting
Meeting on 2 May 20252 May · Board meeting
Apr 2025
16 Apr · Board meeting
8 Apr · Board meeting
Meeting on 16 Apr 2025
Feb 2025
28 Feb · Draft Letter of Offer
24 Feb · Detailed Public Statement
18 Feb · Submission Of Public Announcement To The Public Shareholders Of M/S Chemo Pharma Laboratories Limited
18 Feb · Public Announcement - Open Offer
Jan 2025
27 Jan · Results
13 Jan · Board meeting
Meeting on 27 Jan 2025: quarterly results
Dec 2024
Oct 2024